
Sumitomo Pharma America Presents AUA 2026 Data on Vibegron in Older Men With OAB and BPH
Sumitomo Pharma America Presents AUA 2026 Data Showing Vibegron Benefits in Older Men With Overactive Bladder and BPH Sumitomo Pharma America presented new clinical and real-world evidence from its urology and oncology portfolios at the American Urological Association 2026 Annual…











